Literature DB >> 7047275

Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus.

P Garcia-Webb, A Bonser, T A Welborn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7047275     DOI： 10.1007/bf00281310

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  5 in total

1.  Obesity and insulin secretion in fasting high school students.

Authors:  P Garcia-Webb; A Bonser; K L Wearne; M Gracey
Journal:  Diabetologia       Date:  1980-09       Impact factor: 10.122

2.  C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.

Authors:  O K Faber; C Binder
Journal:  Diabetes       Date:  1977-07       Impact factor: 9.461

3.  Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement.

Authors:  C Eff; O Faber; T Deckert
Journal:  Diabetologia       Date:  1978-09       Impact factor: 10.122

4.  Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.

Authors:  C Hendriksen; O K Faber; J Drejer; C Binder
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

5.  C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.

Authors:  R D Mirel; F Ginsberg-Fellner; D L Horwitz; E J Rayfield
Journal:  Diabetologia       Date:  1980-09       Impact factor: 10.122
  5 in total
  6 in total

1.  Potential beneficial effects of a gluten-free diet in newly diagnosed children with type 1 diabetes: a pilot study.

Authors:  Jannet Svensson; Stine Møller Sildorf; Christian B Pipper; Julie N Kyvsgaard; Julie Bøjstrup; Flemming M Pociot; Henrik B Mortensen; Karsten Buschard
Journal:  Springerplus       Date:  2016-07-07

2.  Impact of flash glucose monitoring on glycemic control varies with the age and residual β-cell function of patients with type 1 diabetes mellitus.

Authors:  Liyin Zhang; Yaling Xu; Xiaofang Jiang; Jieru Wu; Fang Liu; Li Fan; Xia Li; Guangming Yin; Lin Yang
Journal:  J Diabetes Investig       Date:  2021-11-07       Impact factor: 4.232

3.  Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes.

Authors:  Rachel E J Besser; Beverley M Shields; Rosaura Casas; Andrew T Hattersley; Johnny Ludvigsson
Journal:  Diabetes Care       Date:  2012-10-30       Impact factor: 19.112

4.  Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients.

Authors:  Hye-Jin Yoon; Youn-Zoo Cho; Ji-Young Kim; Byung-Joon Kim; Keun-Young Park; Gwan-Pyo Koh; Dae-Ho Lee; Dong-Mee Lim
Journal:  Diabetes Metab J       Date:  2012-10-18       Impact factor: 5.376

5.  Fasting serum C-peptide is useful for initial classification of diabetes mellitus in children and adolescents.

Authors:  Min Jung Cho; Min Sun Kim; Chan Jong Kim; Eun Young Kim; Jong Duk Kim; Eun Young Kim; Dae-Yeol Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-06-30

6.  Islet Function and Insulin Sensitivity in Latent Autoimmune Diabetes in Adults Taking Sitagliptin: A Randomized Trial.

Authors:  Lin Yang; Huiying Liang; Xinyuan Liu; Xia Wang; Ying Cheng; Yunjuan Zhao; Lingjiao Liu; Gan Huang; Xiangbing Wang; Zhiguang Zhou
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.